Search Results

There are 22354 results for: content related to: On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome – an epi-analysis

  1. Risk of fatal and nonfatal lactic acidosis with metformin use in type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Shelley R Salpeter, Elizabeth Greyber, Gary A Pasternak and Edwin E Salpeter

    Published Online : 14 APR 2010, DOI: 10.1002/14651858.CD002967.pub4

  2. Insulin-sensitising drugs (metformin, rosiglitazone, pioglitazone, D-chiro-inositol) for women with polycystic ovary syndrome, oligo amenorrhoea and subfertility

    Intervention Review

    The Cochrane Library

    Thomas Tang, Jonathan M Lord, Robert J Norman, Ephia Yasmin and Adam H Balen

    Published Online : 16 MAY 2012, DOI: 10.1002/14651858.CD003053.pub5

  3. Metformin monotherapy for type 2 diabetes mellitus

    Intervention Review

    The Cochrane Library

    Antonio Saenz, Inmaculada Fernandez-Esteban, Angel Mataix, Monica Ausejo Segura, Marta Roqué i Figuls and David Moher

    Published Online : 20 JUL 2005, DOI: 10.1002/14651858.CD002966.pub3

  4. Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 3, March 2013, Pages: 204–212, M. Nauck, A. Frid, K. Hermansen, A. B. Thomsen, M. During, N. Shah, T. Tankova, I. Mitha and D. R. Matthews

    Article first published online : 11 OCT 2012, DOI: 10.1111/dom.12012

  5. The effect of initial therapy with the fixed-dose combination of sitagliptin and metformin compared with metformin monotherapy in patients with type 2 diabetes mellitus

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 7, July 2011, Pages: 644–652, C. Reasner, L. Olansky, T. L. Seck, D. E. Williams-Herman, M. Chen, L. Terranella, A. O. Johnson-Levonas, K. D. Kaufman and B. J. Goldstein

    Article first published online : 24 MAY 2011, DOI: 10.1111/j.1463-1326.2011.01390.x

  6. Metformin treatment before and during IVF or ICSI in women with polycystic ovary syndrome

    Intervention Review

    The Cochrane Library

    L O Tso, Michael F Costello, Régis B Andriolo and Vilmon Freitas

    Published Online : 15 APR 2009, DOI: 10.1002/14651858.CD006105.pub2

  7. Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 10, October 2009, Pages: 966–977, S. S. Lund, L. Tarnow, A. S. Astrup, P. Hovind, P. K. Jacobsen, A. C. Alibegovic, I. Parving, L. Pietraszek, M. Frandsen, P. Rossing, H.-H. Parving and A. A. Vaag

    Article first published online : 25 JUN 2009, DOI: 10.1111/j.1463-1326.2009.01079.x

  8. Initial combination therapy with saxagliptin and metformin provides sustained glycaemic control and is well tolerated for up to 76 weeks

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 6, June 2011, Pages: 567–576, A. Pfützner, E. Paz-Pacheco, E. Allen, R. Frederich, R. Chen and for the CV181039 Investigators

    Article first published online : 20 APR 2011, DOI: 10.1111/j.1463-1326.2011.01385.x

  9. Metformin-glibenclamide versus metformin plus rosiglitazone in patients with type 2 diabetes inadequately controlled on metformin monotherapy

    Diabetes, Obesity and Metabolism

    Volume 8, Issue 2, March 2006, Pages: 156–163, A. Garber, E. Klein, S. Bruce, S. Sankoh and P. Mohideen

    Article first published online : 19 DEC 2005, DOI: 10.1111/j.1463-1326.2005.00570.x

  10. Insulin-sensitising drugs versus the combined oral contraceptive pill for hirsutism, acne and risk of diabetes, cardiovascular disease, and endometrial cancer in polycystic ovary syndrome

    Intervention Review

    The Cochrane Library

    Michael F Costello, Bhushan Shrestha, John Eden, Neil Johnson and Lisa J Moran

    Published Online : 24 JAN 2007, DOI: 10.1002/14651858.CD005552.pub2

  11. Metformin induces PGC-1α expression and selectively affects hepatic PGC-1α functions

    British Journal of Pharmacology

    Volume 171, Issue 9, May 2014, Pages: 2351–2363, Sanna-Mari Aatsinki, Marcin Buler, Henriikka Salomäki, Markku Koulu, Petr Pavek and Jukka Hakkola

    Article first published online : 11 APR 2014, DOI: 10.1111/bph.12585

  12. You have free access to this content
    Loss of multidrug and toxin extrusion 1 (MATE1) is associated with metformin-induced lactic acidosis

    British Journal of Pharmacology

    Volume 166, Issue 3, June 2012, Pages: 1183–1191, K Toyama, A Yonezawa, S Masuda, R Osawa, M Hosokawa, S Fujimoto, N Inagaki, K Inui and T Katsura

    Article first published online : 8 MAY 2012, DOI: 10.1111/j.1476-5381.2012.01853.x

  13. A treatment strategy implementing combination therapy with sitagliptin and metformin results in superior glycaemic control versus metformin monotherapy due to a low rate of addition of antihyperglycaemic agents

    Diabetes, Obesity and Metabolism

    Volume 13, Issue 9, September 2011, Pages: 841–849, L. Olansky, C. Reasner, T. L. Seck, D. E. Williams-Herman, M. Chen, L. Terranella, A. Mehta, K. D. Kaufman and B. J. Goldstein

    Article first published online : 26 JUL 2011, DOI: 10.1111/j.1463-1326.2011.01416.x

  14. You have free access to this content
    Efficacy and safety of monotherapy of sitagliptin compared with metformin in patients with type 2 diabetes

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 3, March 2010, Pages: 252–261, P. Aschner, H. L. Katzeff, H. Guo, S. Sunga, D. Williams-Herman, K. D. Kaufman, B. J. Goldstein and for the Sitagliptin Study 049 Group

    Article first published online : 25 NOV 2009, DOI: 10.1111/j.1463-1326.2009.01187.x

  15. Metformin vs. insulin in gestational diabetes. A randomized study characterizing metformin patients needing additional insulin

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 3, March 2013, Pages: 246–251, K. Tertti, U. Ekblad, P. Koskinen, T. Vahlberg and T. Rönnemaa

    Article first published online : 24 OCT 2012, DOI: 10.1111/dom.12017

  16. Characterization of metformin transport system in NIH 3T3 cells

    Journal of Cellular Physiology

    Volume 152, Issue 2, August 1992, Pages: 310–316, Naim A. Khan, Nicolas Wiernsperger, Veronique Quemener, René Havouis and Jacques P. Moulinoux

    Article first published online : 4 FEB 2005, DOI: 10.1002/jcp.1041520212

  17. Involvement of carnitine/organic cation transporter OCTN1/SLC22A4 in gastrointestinal absorption of metformin

    Journal of Pharmaceutical Sciences

    Volume 102, Issue 9, September 2013, Pages: 3407–3417, Noritaka Nakamichi, Hiroyo Shima, Satoshi Asano, Takahiro Ishimoto, Tomoko Sugiura, Kazuki Matsubara, Hiroyuki Kusuhara, Yuichi Sugiyama, Yoshimichi Sai, Ken-Ichi Miyamoto, Akira Tsuji and Yukio Kato

    Article first published online : 10 MAY 2013, DOI: 10.1002/jps.23595

  18. You have free access to this content
    The effects of metformin on the survival of colorectal cancer patients with diabetes mellitus

    International Journal of Cancer

    Volume 131, Issue 3, 1 August 2012, Pages: 752–759, Jin Ha Lee, Tae Il Kim, Soung Min Jeon, Sung Pil Hong, Jae Hee Cheon and Won Ho Kim

    Article first published online : 20 OCT 2011, DOI: 10.1002/ijc.26421

  19. Metformin in Noninsulin-Dependent Diabetes Mellitus

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 16, Issue 3, May-June 1996, Pages: 327–351, Audrey Jade Lee

    Article first published online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1996.tb02964.x

  20. Efficacy and safety of alogliptin added to metformin in Japanese patients with type 2 diabetes: a randomized, double-blind, placebo-controlled trial with an open-label, long-term extension study

    Diabetes, Obesity and Metabolism

    Volume 14, Issue 10, October 2012, Pages: 927–936, Y. Seino, Y. Miyata, S. Hiroi, M. Hirayama and K. Kaku

    Article first published online : 5 JUN 2012, DOI: 10.1111/j.1463-1326.2012.01620.x